PARP Inhibitor–Based Combinations to Improve Patient Outcomes in Prostate Cancer: An Evidence-Based Global Perspective

Download All
Learn about PARP inhibitor–based combination therapy in prostate cancer in this expert-authored online activity with downloadable slides, podcasts and a ClinicalThought.
Charles J. Ryan, MD

CME Expert-Authored, Interactive Online Activity

Review expert insights on PARP inhibitor combination approaches including combinations with AR-directed therapy and immune checkpoint inhibitors.

Charles J. Ryan, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: April 12, 2021 Expired: No longer available for credit

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings